SPOTLIGHT: Astex in licensing deal with Glaxo


Astex Therapeutics pocketed an unspecified upfront payment in a licensing deal with GlaxoSmithKline. Glaxo won a nonexclusive license for Astex's cytochrome P450 intellectual property. Cytochromes P450 are drug-metabolizing enzymes. Release